Boron API Manufacturers & Suppliers
0 verified results
All Boron data. Full access. Full negotiation power
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Boron | CAS No: 7440-42-8 | GMP-certified suppliers
A medication that serves as a trace element involved in physiological and nutritional functions, with specialized applications in antiseptic and antifungal boron-containing compounds.
Therapeutic categories
Product Snapshot
- Boron is available in multiple oral solid dosage forms including capsules, film-coated tablets, wafers, and chewable tablets
- It is primarily investigated for experimental therapeutic applications
- Boron is currently in the experimental stage with no approved status in the US market
Clinical Overview
In pharmaceutical and biological contexts, boron itself does not have an established clinical indication or approved medicinal use as a standalone active pharmaceutical ingredient (API). However, boron-containing compounds, such as boric acid, possess antiseptic, antifungal, and antiviral activities; boric acid finds limited application in topical treatments and as a water clarifier in swimming pools. A small number of pharmaceutical agents incorporate boron atoms into their molecular structures, serving experimental or specialized roles, but these are not widely prevalent in clinical practice. The pharmacodynamics and explicit mechanism of action of elemental boron or its derivatives in medical therapy remain largely unspecified.
From a pharmacokinetic perspective, detailed absorption, distribution, metabolism, and excretion (ADME) parameters for elemental boron as a drug substance are not well defined. Boron is recognized primarily as an essential trace element involved in physiological phenomena and micronutrient functions rather than traditional pharmacology.
Safety and toxicity data specific to the elemental API are limited; however, boron compounds exhibit dose-dependent toxicity and require careful handling. Regulatory approval status classifies this compound in the experimental category without established therapeutic claims.
Boron is widely used industrially in ceramics, abrasives, metal coatings, detergents, insecticides, semiconductors, magnets, wood preservatives, and boron-containing fiberglass for insulation and structural materials. This diverse usage necessitates stringent quality control when sourcing API-grade boron to avoid contamination and ensure consistency for any potential pharmaceutical application. Procurement should prioritize suppliers who provide verified purity and comply with international standards for elemental contaminants.
Identification & chemistry
| Generic name | Boron |
|---|---|
| Molecule type | Small molecule |
| CAS | 7440-42-8 |
| UNII | N9E3X5056Q |
| DrugBank ID | DB11203 |
Formulation & handling
- Boron is formulated exclusively for oral administration in various solid dosage forms such as capsules, tablets, and wafers.
- As a small inorganic metalloid compound with low molecular weight and moderate logP, boron exhibits favorable absorption characteristics for oral delivery.
- Formulation should consider stability under standard oral dosage form conditions without special handling for sensitivity to food or moisture.
Regulatory status
| Lifecycle | The API's primary patents have expired, allowing generic versions to enter the US market, resulting in a mature product lifecycle with established usage and pricing dynamics. |
|---|
| Markets | US |
|---|
Supply Chain
| Supply chain summary | The Boron supply landscape features several originator companies responsible for developing and marketing branded products such as Calcemin and Folitin-Z primarily in the US market. These branded formulations demonstrate a focused global presence limited to this region, with no specified markers in the EU or other markets. Patent statuses suggest potential opportunities for generic competition, depending on individual product life cycles. |
|---|
Boron is a type of Antifungals
Antifungals are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) designed to combat fungal infections. These medications are developed to target and eliminate fungi, including yeasts and molds, which can cause a range of diseases in humans and animals.
Antifungals work by interfering with specific components or processes essential for fungal growth and reproduction. They may inhibit the synthesis of fungal cell walls or disrupt the production of ergosterol, a crucial component of fungal cell membranes. By targeting these key mechanisms, antifungal APIs effectively hinder the growth and spread of fungal infections.
The diversity within the antifungal category is reflected in the various classes of antifungal APIs available. Azoles, polyenes, echinocandins, and allylamines are common classes of antifungals. Each class exhibits unique mechanisms of action and targets specific types of fungi. This diversity enables healthcare professionals to tailor treatment plans to the specific fungal infection, optimizing therapeutic outcomes.
Antifungal APIs find application in various pharmaceutical formulations, including oral medications, topical creams, ointments, and intravenous solutions. They are crucial for the treatment of common fungal infections like athlete's foot, ringworm, vaginal yeast infections, and oral thrush. Additionally, antifungals play a crucial role in managing serious systemic fungal infections that can pose significant health risks, especially in immunocompromised individuals.
Overall, antifungal APIs are indispensable tools in the fight against fungal infections, offering effective treatment options and improving the quality of life for patients suffering from these conditions. With ongoing research and development, the antifungal category continues to evolve, providing innovative solutions to combat the ever-changing landscape of fungal pathogens.
